期刊文献+

急性心肌梗死患者半乳凝素-3血清水平变化及其相关性研究 被引量:1

The change and correlation study of serum galectin-3 in patients with acute myocardial infarction
下载PDF
导出
摘要 目的 探讨心肌梗死患者急性期半乳凝素-3(Gal-3)的血清水平动态变化,以及与急性心肌梗死患者前脑钠肽(proBNP)、高敏C反应蛋白(hs-CRP)及冠脉病变程度的相关性.方法 选择急性心肌梗死(AMI组)患者52例及健康体检者(对照组)31例,采用酶联免疫吸附法测定AMI组发病24 h内、第3天、第7天的血清Gal-3,以及发病24h内的proBNP、hs-CRP水平,记录冠脉病变程度.结果 AMI组24 h内、第3天、第7天Gal-3水平分别为(12.58±1.98)ng/ml、(11.26±1.64)ng/ml、(9.61±1.02)ng/ml,均较正常对照组(4.64±1.34)ng/ml、(4.58±1.36)ng/ml、(4.69±1.41)ng/ml明显升高(P<0.01);且AMI组Gal-3水平24h内高于第3天,第3天高于第7天(P均<0.01);同时AMI组24 h内Gal-3、proBNP、hs-CRP水平分别为(12.58±1.98)ng/ml、(763.40±232.32)pg/ml、(6.50±0.91) μmol/L,均比对照组(4.64±1.34)ng/ml、(147.45±61.43)pg/ml、(2.26±0.93)μmol/L明显升高(P均<0.01).Gal-3与proBNP、hs-CRP水平呈正相关(r=0.525,r=0.492,P均<0.01).Gal-3、proBNP与冠状动脉病变支数、冠状动脉Gensini评分呈正相关(r=0.359,r=0.479,P均<0.01).结论 AMI患者血清Gal-3水平明显升高,并在发病24h内升高最明显.Gal-3与proBNP、hs-CRP水平及冠状动脉病变程度间存在相关性. Objective To observe the change of serum galectin-3 (Gal-3) levels in patients with acute myocardial infarction (AMI) and to explore the correlation between galectin-3 and pro-brain natriuretic pep (proBNP), high-sensitivity C-reactive protein (hs-CRP), coronary artery disease severity. Methods Fifty-two AMI patients (AMI group) and thirty-one healthy subjects (control group) were enrolled. Enzyme linked immunosorbent assay were used to measure the serum Gal-3 levels of AMI within 24 h, third day, seventh day and serum proBNP, hs-CRP level of AMI within 24 h, and the coronary artery disease severity were record. Results In AMI group within 24 hours, the 3rd day and the 7th day, the level of Gal-3 were (12.58±1.98)ng/ ml, (11.26±1.64)ng/ml and (9.61±1.02)ng/ml, compared with the normal control group (4.64 ±1.34)ng/ml, (4.58±1.36)ng/ml, (4.69±1.41)ng/ml, there were increased significantly (P〈0.01), and in AMI group Gal-3 levels were higher within 24 hours than the 3rd day, the 3rd day longer than 7th day (P〈0.01), and in AMI group within 24 h of Gal-3, proBNP, hs CRP levels were (12.58±1.98)ng/ml, (763.40±232.32)pg/ml, (6.50± 0.91 )μmol/L, which increased more significantly than those of the control group (4.64±1.34)ng/ml, (147.45± 61.43)pg/ml, (2.26±0.93)μmol/L (P〈0.01). Serum Gal-3 level in AMI group was much higher than that in healthy control group (P〈0.01), Serum Gal-3 level of AMI within 24 h was higher than that of third day, serum Gal-3 level of third day was higher than that of seventh day (all P〈0.01 ), and Gal-3 was positively correlated with proBNP, hs-CRP (r=0.525, r=0.492, P〈0.01), serum Gal-3, proBNP and hs-CRP levels in AMI group were much higher than that in healthy control group (all P〈0.01 ), and Gal-3, proBNP were positively correlated with coronary artery lesions counts and Gensini score(r=0.359, r=0.479, all P〈0.05). Conchmion Serum Gal-3 level in AMI group is high and keep increasing within 24 h. Ga1-3 is correlate with pruBNP, hs-CRP and coronary artery disease severity.
作者 王锐
出处 《中国心血管病研究》 CAS 2015年第10期901-904,共4页 Chinese Journal of Cardiovascular Research
关键词 急性心肌梗死 半乳凝素-3 前脑钠肽 高敏C反应蛋白 Acute myocardial infarction Galectin-3 Pro-brain natriuretic-pep High-sensitivity C-reactive protein
  • 相关文献

参考文献14

  • 1李兆欣,翟朝晖,李耀民,郭园园,李臣文.Gal-3与急性心肌梗死后心功能的相关性及瑞舒伐他汀的干预作用[J].中国医学创新,2014,11(32):8-11. 被引量:2
  • 2Gensini GG. Amoremeaningful scoring sy stem for determining the severity of coronary heart disease. Am J Cardiol, 1983,51:606.
  • 3Papaspyridonos M, McNeill E, de Bono JP, et al. Galectin-3 isan amplifier of inflammation in atherosclerotic plaque progressionthrough macrophage activation and monocyte chemoattraction. Ar-terioscler Thromb Vase Biol, 2008,28 : 433-440.
  • 4Fernandes Bertocchi AP, Campanhole G, Wang PH, et al. Arolefor glectin -3 in renal tissue damage triggered by ischemia andreperfusion injury. Transpl Int,2008,21:999-1007.
  • 5Krzeslak A, Lipinska A. Galenctin-3 as a multifunctional pro-tein. Cell Mol Bilo Lett,2004,9:305-328.
  • 6Nachtigal M, Al-Assaad Z, Mayer EP, et al. Galectin-3 expres-sion in human atherosclerotic lesions. Am J Pathol, 1998,5 :1199-1208.
  • 7马晓艳,张言镇,周衍菊.急性冠脉综合征患者血清血管内皮生长因子、缺氧诱导因子-1α水平的变化及临床意义[J].中国心血管病研究,2008,6(12):921-923. 被引量:4
  • 8Leffler H, Carlsson S, Hedlund M, et al. Introduction togalectins. Gaycoconj J,2004,19:433-440.
  • 9周丽程,郑杨.脑钠素、N-末端脑钠素前体与心血管疾病[J].中国心血管病研究,2007,5(12):937-939. 被引量:11
  • 10plasma galectin -3 to renal function in patients with heartfailure: effects clinical status, pathophysiology of heart failure,and presence or absence of heart failure. J Am Heart Assoc,2013,l:e00760.

二级参考文献34

  • 1孙璐,韦立新,石怀银,郭爱桃,侯宁,游联璧.冠状动脉粥样硬化斑块内血管新生与斑块稳定的关系[J].中华病理学杂志,2003,32(5):427-431. 被引量:42
  • 2肖春晖,吴小庆,羊镇宇,李肖蓉,王如兴.B型利钠肽与孤立性心房颤动[J].中国循环杂志,2007,22(1):31-34. 被引量:12
  • 3[1]Weber M,Hamm C.Role of B-type natriuretic peptide and NT-proBNP in clinical routine.Heart,2006,92:843-849.
  • 4[2]Mueller C,Scloler A,loule-Kilian K,et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.N Engl J Med,2004,350:647-54.
  • 5[3]Steg PG,Joubin L,Mecord Jet al.B-Type natriuretic peptide and echocardio graphic determination of ejection fractioninthe diagnosis of congestive heart failure in patients with acute dyspnea.CHEST,2005,128:21-29.
  • 6[4]Januzzi JL Jr,Camargo CA,Anwaruddin S,et al.The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.Am J Cardiol,2005,95:948-954.
  • 7[5]Odar-Cederlof I,Bjellerup P,Williams A,et al.Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP),a biomarker of left ventricular dysfunction.Hemodial Int,2006,10:394-398.
  • 8[6]Knebel F,Schimke l,Plief K,et al.NT-ProBNP in acute heart failure:correlation with invasively measured hemodynamic parameters during recompensation.J Card Fail,2005,11(Suppl 5):S38-S41.
  • 9[8]Heart Protection Study Collaborative Group,Emberson JR.N-terminal Pro-B-type natriu retic peptide,vascular disease risk,and cholesterol reduction among 20 536 patients in the MRC/BHF heart protection study.J Am Coll Car diol,2007,49:311-319.
  • 10[9]Brenden CK,Hollander JE,Guss D,et al.Gray zone BNP levels in heart failure patients in the emergen cy department:results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study.Am Heart J,2006,151:1006-1011.

共引文献14

同被引文献8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部